Company news

4basebio PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Result of Retail Offer

October 21, 2026

Posting of Circular and Notice of General Mee...

October 20, 2026

4basebio Plc - Proposed Retail Offer

October 15, 2026

Proposed Retail Offer

October 15, 2026

Results of Capital Raise

October 15, 2026

Proposed Capital Raise of New Ordinary Shares...

October 15, 2026

4basebio PLC - Half-year Report for the six months ended 30 June 2026

September 29, 2026

4basebio and TriLink BioTechnologies Partner...

September 28, 2026

4basebio Expands DNA Offering to Meet Growing...

September 7, 2026

4basebio and Genezen Enter into Strategic Col...

August 26, 2026

4basebio Plc - Grant of Options & Director/PDMR Dealing

July 22, 2026

Director Appointment

July 8, 2026

4basebio Plc - Result of AGM & Issue of Options

June 30, 2026

Notice of Investor Presentation

June 16, 2026

4basebio Appoints Dr. Jeff Coller to Strategi...

June 15, 2026

Notice of Annual General Meeting

June 5, 2026

4basebio Plc - Director Dealing

May 22, 2026

4basebio Plc - 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial

May 20, 2026

Appointment of Chief Financial Officer and Bo...

May 14, 2026

4basebio Launches Enzymatic ssDNA Platform

May 11, 2026

Lease of Manufacturing Facility

March 31, 2026

Appointment of COO

March 12, 2026

4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer

March 3, 2026

Leadership Changes

February 10, 2026

Synthetic opDNA® utilised in Phase I/II US cl...

October 27, 2025

Result of Extraordinary General Meeting

October 10, 2025

Director Dealing

September 30, 2025

Half-year Report

September 29, 2025

Employee Long Term Incentive Plan and Issue o...

July 22, 2025

Director Appointment, Board Change

July 8, 2025

Holding(s) in Company

July 3, 2025

4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies

July 1, 2025

Result of AGM

June 27, 2025

Exercise of Options

June 25, 2025

Final Results and Notice of AGM

May 27, 2025

4basebio Receives GMP Licence for its UK DNA...

April 2, 2025

RBC Capital Markets initiates research covera...

March 14, 2025

Director's Dealing

March 3, 2025

Appointment of Chief Commercial Officer

January 8, 2025

Directorate Change

December 17, 2024

Appointment of Joint Corporate Broker

November 14, 2024

Completion of Strategic Investment

November 12, 2024

Update re Equity Issuance, Secondary Sale and...

September 9, 2024

Strategic Advisory Board & Appointment of Dir...

August 8, 2024

£40.0m Equity Issuance and £29.4m Secondary S...

July 29, 2024

4basebio announces the supply of its opDNA™ D...

April 10, 2024

4basebio client's Phase I clinical trials for...

March 21, 2024

4basebio awarded tender to deliver research a...

March 1, 2024

Directors' Dealings

February 5, 2024

Long-Term Incentive Plan and Exercise of Opti...

February 2, 2024

Older news releases →

Calls

The 5 newest of 6 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.